| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Clinical Dialysis |



* Division of Nephrology and Hypertension, Department of Internal Medicine; and
Inha Kidney Disease Research Group, Inha University College of Medicine, Incheon, Korea
Address correspondence to: Dr. Moon-Jae Kim MD, Kidney Center, Inha University Hospital, 7-206 Sinhung-Dong Jung-Gu, Incheon, 400-103, Korea. Phone: 82-32-890-2538; Fax: 82-32-883-6578; E-mail: nhkimj{at}inha.ac.kr
Excessive sodium gain is a major hindrance of sodium profiling hemodialysis (HD) that offsets the benefit in reducing intradialytic hypotension-related discomforts (IHD). Patients who showed frequent IHD (>30% of the sessions; n = 11) were enrolled in a prospective study that consisted of two phases. In the phase 1 study, eight treatment modalities were evaluated: Conventional HD (control), sodium balancepositive step-down sodium profiling HD (PS), sodium balanceneutral step-down sodium profiling HD (NS), sodium balanceneutral alternating sodium profiling HD (NA) without ultrafiltration (UF) profile, and all those with UF profile (UF only, PS+U, NS+U, and NA+U). The incidences of "dialysis failure," defined as the occurrence of one or more of (1) session failure (discontinuation of session <75% of planned time), (2) UF failure (%UF achieved <70%), and (3) delivery failure (Kt/V <1.1), were 48.5, 21.2, 42.4, 39.4, 45.5, 18.2, 21.2, and 18.2% in control, PS, NS, NA, UF only, PS+U, NS+U, and NA+U, respectively. Four treatments, PS, PS+U, NS+U, and NA+U, reduced the incidence of dialysis failure significantly as compared with control (P < 0.05) and were evaluated in the phase 2 study, a randomized controlled 6-wk crossover study. Parameters were measured in the steady state after a 6-wk maintenance of each treatment. Diffusive sodium gain (
Na) was significantly increased with sodium balancepositive profiles with or without UF profile, PS and PS+U (PS 1.9 ± 1.1, PS+U 1.7 ± 1.0 mEq/L; both P < 0.05 to control 0.1 ± 0.2, NS+U 0.5 ± 0.4, NA+U 0.4 ± 0.2 mEq/L). They also increased the interdialytic weight gain (PS 3.8 ± 0.6, PS+U 4.0 ± 0.6 kg; both P < 0.05 to control 2.7 ± 0.6, NS+U 3.3 ± 0.6 kg; both P = NS to NA+U 3.5 ± 0.6 kg). Predialysis weight and the required amount of UF also increased significantly with these sodium balancepositive profiles. Although the absolute amount of UF was larger with PS and PS+U, %UF achieved targeting dry weight was higher with sodium balanceneutral profiles with UF profiles, NS+U and NA+U (NS+U 92.7 ± 3.8, NA+U 93.7 ± 6.8%; both P < 0.05 to control 72.6 ± 14.0, PS 88.3 ± 6.6, PS+U 88.2 ± 8.2%). Postdialysis weight was closest to dry weight with these treatments showing
(postdialysis weight dry weight) of 0.3 ± 0.1 and 0.3 ± 0.2 kg in NS+U and NA+U (both P < 0.05 to control 1.0 ± 0.6 kg; both P = NS to PS 0.5 ± 0.3, PS+U 0.5 ± 0.4 kg). Incidence of excessive weight gain and subjective discomforts during the interdialytic period increased significantly with PS. In conclusion, continuous use of sodium balancepositive sodium profiles resulted in an undesirable steady state with sodium and fluid expansion offsetting their hemodynamic benefit. Sodium balanceneutral sodium profiles in combination with UF profile were associated with less sodium and weight gains, better UF performance with postdialysis weight closest to dry weight, and fewer interdialytic problems with the equivalent hemodynamic benefit. Therefore, it is proposed that sodium balanceneutral sodium profiling HD with UF profile is a better choice, ensuring the dialysis of quality without sodium gainrelated complications.
This article has been cited by other articles:
![]() |
B. F. Palmer and W. L. Henrich Recent Advances in the Prevention and Management of Intradialytic Hypotension J. Am. Soc. Nephrol., January 1, 2008; 19(1): 8 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. L. Zhou, H. L. Liu, X. F. Duan, Y. Yao, Y. Sun, and Q. Liu Impact of sodium and ultrafiltration profiling on haemodialysis-related hypotension Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3231 - 3237. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Narins, Participants:, M. Halperin, G. Danovitch, R. Falk, and J. Bargman The Nephrology Quiz and Questionnaire: 2005 Clin. J. Am. Soc. Nephrol., May 1, 2006; 1(3): 592 - 608. [Full Text] [PDF] |
||||
![]() |
K. Jindal, C. T. Chan, C. Deziel, D. Hirsch, S. D. Soroka, M. Tonelli, and B. F. Culleton CHAPTER 2: Management of Blood Pressure in Hemodialysis Patients J. Am. Soc. Nephrol., March 1, 2006; 17(3_suppl_1): S8 - S10. [Full Text] [PDF] |
||||
![]() |
K. Moret, J. Aalten, W. van den Wall Bake, P. Gerlag, C. Beerenhout, F. van der Sande, K. Leunissen, and J. Kooman The effect of sodium profiling and feedback technologies on plasma conductivity and ionic mass balance: a study in hypotension-prone dialysis patients Nephrol. Dial. Transplant., January 1, 2006; 21(1): 138 - 144. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673